| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047725870 |
| P356 | DOI | 10.1038/APS.2010.97 |
| P953 | full work available at URL | https://www.nature.com/articles/aps201097.pdf |
| http://www.chinaphar.com/1671-4083/31/970.htm | ||
| https://doi.org/10.1038/aps.2010.97 | ||
| https://europepmc.org/articles/PMC4007816 | ||
| https://europepmc.org/articles/PMC4007816?pdf=render | ||
| P932 | PMC publication ID | 4007816 |
| P698 | PubMed publication ID | 20686521 |
| P5875 | ResearchGate publication ID | 45505921 |
| P2093 | author name string | Hong-mei Yin | |
| Jiong Mei | |||
| Xiao-zhong Zhu | |||
| P2860 | cites work | Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer | Q28376841 |
| Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis | Q29614537 | ||
| High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study | Q33342456 | ||
| Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. | Q33369033 | ||
| Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma | Q33728605 | ||
| Current treatment of osteosarcoma | Q34242261 | ||
| Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice | Q34432972 | ||
| Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. | Q34532932 | ||
| Primary bone osteosarcoma in the pediatric age: state of the art. | Q34550193 | ||
| Osteosarcoma: a multidisciplinary approach to diagnosis and treatment | Q34582642 | ||
| Chemotherapy resistance in osteosarcoma: current challenges and future directions. | Q36532115 | ||
| Anti-angiogenic therapy for osteosarcoma. | Q36679552 | ||
| Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease | Q37486254 | ||
| Regulation of tumor angiogenesis by the local environment | Q37663176 | ||
| The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli | Q39240570 | ||
| Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy | Q39340821 | ||
| Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma | Q39695611 | ||
| Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. | Q39744728 | ||
| A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. | Q40190843 | ||
| Advances and treatment of primary bone tumors | Q40576889 | ||
| Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation | Q40714513 | ||
| Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer | Q41740928 | ||
| "Metronomic" chemotherapy in advanced soft tissue sarcomas | Q43150686 | ||
| Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts | Q43860650 | ||
| Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults | Q44190022 | ||
| Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome | Q44649234 | ||
| Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas | Q46270898 | ||
| Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors. | Q53923633 | ||
| miRNA-regulated expression of oncogenes and tumor suppressor genes in the cisplatin-inhibited growth of K562 cells. | Q54430359 | ||
| Low-voltage electrochemotherapy with low-dose methotrexate enhances survival in mice with osteosarcoma | Q80523074 | ||
| Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue | Q82758087 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 970-976 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy | |
| P478 | volume | 31 |
| Q36261555 | Programmed cell death 2 functions as a tumor suppressor in osteosarcoma | cites work | P2860 |
Search more.